Search

Catherine Ho

Examiner (ID: 13990)

Most Active Art Unit
2924
Art Unit(s)
2953, 2924
Total Applications
1329
Issued Applications
1227
Pending Applications
20
Abandoned Applications
93

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16175594 [patent_doc_number] => 20200222562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => STABILIZATION OF RADIOPHARMACEUTICAL COMPOSITIONS USING ASCORBIC ACID [patent_app_type] => utility [patent_app_number] => 16/551588 [patent_app_country] => US [patent_app_date] => 2019-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7473 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16551588 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/551588
STABILIZATION OF RADIOPHARMACEUTICAL COMPOSITIONS USING ASCORBIC ACID Aug 25, 2019 Abandoned
Array ( [id] => 17140276 [patent_doc_number] => 20210308287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => METHOD FOR EXTRACTION AND PURIFICATION OF 68GA [patent_app_type] => utility [patent_app_number] => 17/265138 [patent_app_country] => US [patent_app_date] => 2019-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9600 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -89 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17265138 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/265138
Method for extraction and purification of 68GA Aug 1, 2019 Issued
Array ( [id] => 15087059 [patent_doc_number] => 20190338340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-07 [patent_title] => 5,5-DISUBSTITUTED LUCIFERINS AND THEIR USE IN LUCIFERASE-BASED ASSAYS [patent_app_type] => utility [patent_app_number] => 16/516974 [patent_app_country] => US [patent_app_date] => 2019-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16674 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16516974 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/516974
5,5-disubstituted luciferins and their use in luciferase-based assays Jul 18, 2019 Issued
Array ( [id] => 17805875 [patent_doc_number] => 20220257710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => ANTI-INFECTION EFFECTS OF HNRNPA2B1 AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/627805 [patent_app_country] => US [patent_app_date] => 2019-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7543 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627805 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/627805
ANTI-INFECTION EFFECTS OF HNRNPA2B1 AND USE THEREOF Jul 16, 2019 Pending
Array ( [id] => 16969404 [patent_doc_number] => 11065351 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-20 [patent_title] => Methods for diagnosing and monitoring eosinophilic esophagitis [patent_app_type] => utility [patent_app_number] => 16/502328 [patent_app_country] => US [patent_app_date] => 2019-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10971 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16502328 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/502328
Methods for diagnosing and monitoring eosinophilic esophagitis Jul 2, 2019 Issued
Array ( [id] => 17406079 [patent_doc_number] => 11246940 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-15 [patent_title] => Peptides whose uptake in cells is controllable [patent_app_type] => utility [patent_app_number] => 16/457763 [patent_app_country] => US [patent_app_date] => 2019-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 39792 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16457763 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/457763
Peptides whose uptake in cells is controllable Jun 27, 2019 Issued
Array ( [id] => 14991141 [patent_doc_number] => 20190314528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => TARGETED THERAPEUTICS [patent_app_type] => utility [patent_app_number] => 16/454586 [patent_app_country] => US [patent_app_date] => 2019-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34014 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16454586 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/454586
TARGETED THERAPEUTICS Jun 26, 2019 Abandoned
Array ( [id] => 14990653 [patent_doc_number] => 20190314284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => Cleavable Lipids [patent_app_type] => utility [patent_app_number] => 16/452353 [patent_app_country] => US [patent_app_date] => 2019-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25654 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16452353 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/452353
Cleavable lipids Jun 24, 2019 Issued
Array ( [id] => 17306350 [patent_doc_number] => 11207433 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-28 [patent_title] => Imaging agents and uses thereof [patent_app_type] => utility [patent_app_number] => 16/449147 [patent_app_country] => US [patent_app_date] => 2019-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 8323 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16449147 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/449147
Imaging agents and uses thereof Jun 20, 2019 Issued
Array ( [id] => 19134575 [patent_doc_number] => 11969484 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-30 [patent_title] => Composition containing a somatostatin analogue for radiopharmaceutical use [patent_app_type] => utility [patent_app_number] => 17/251426 [patent_app_country] => US [patent_app_date] => 2019-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7619 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251426 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/251426
Composition containing a somatostatin analogue for radiopharmaceutical use Jun 19, 2019 Issued
Array ( [id] => 19273280 [patent_doc_number] => 12023387 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-02 [patent_title] => NIR-II emissive luminogens [patent_app_type] => utility [patent_app_number] => 17/251961 [patent_app_country] => US [patent_app_date] => 2019-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 21 [patent_no_of_words] => 5014 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251961 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/251961
NIR-II emissive luminogens Jun 13, 2019 Issued
Array ( [id] => 16941001 [patent_doc_number] => 11053222 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-06 [patent_title] => Fluorescent compounds [patent_app_type] => utility [patent_app_number] => 16/436512 [patent_app_country] => US [patent_app_date] => 2019-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 81 [patent_no_of_words] => 25909 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16436512 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/436512
Fluorescent compounds Jun 9, 2019 Issued
Array ( [id] => 18664915 [patent_doc_number] => 11771780 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-03 [patent_title] => Method for preparing an Fe-tCDTA contrast agent and product obtainable by the method [patent_app_type] => utility [patent_app_number] => 17/252261 [patent_app_country] => US [patent_app_date] => 2019-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2376 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17252261 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/252261
Method for preparing an Fe-tCDTA contrast agent and product obtainable by the method Jun 5, 2019 Issued
Array ( [id] => 15264933 [patent_doc_number] => 20190381200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-19 [patent_title] => FREE PSA ANTIBODIES AS DIAGNOSTICS, PROGNOSTICS AND THERAPEUTICS FOR PROSTATE CANCER [patent_app_type] => utility [patent_app_number] => 16/430041 [patent_app_country] => US [patent_app_date] => 2019-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32395 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16430041 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/430041
Free PSA antibodies as diagnostics, prognostics and therapeutics for prostate cancer Jun 2, 2019 Issued
Array ( [id] => 16946793 [patent_doc_number] => 20210205484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => SPATIAL MAPPING OF KIDNEY FUNCTIONS [patent_app_type] => utility [patent_app_number] => 17/059606 [patent_app_country] => US [patent_app_date] => 2019-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6896 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059606 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/059606
Spatial mapping of kidney functions May 30, 2019 Issued
Array ( [id] => 17748131 [patent_doc_number] => 20220226334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => ANTIBODY CONJUGATE AND APPLICATION OF PHARMACEUTICAL COMPOSITION THEREOF [patent_app_type] => utility [patent_app_number] => 17/612849 [patent_app_country] => US [patent_app_date] => 2019-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13485 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612849 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/612849
ANTIBODY CONJUGATE AND APPLICATION OF PHARMACEUTICAL COMPOSITION THEREOF May 20, 2019 Abandoned
Array ( [id] => 16175596 [patent_doc_number] => 20200222564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => Compound Amphiphilic Peptide Nanomicelle, Preparation and Use Thereof [patent_app_type] => utility [patent_app_number] => 16/393784 [patent_app_country] => US [patent_app_date] => 2019-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4109 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16393784 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/393784
Compound Amphiphilic Peptide Nanomicelle, Preparation and Use Thereof Apr 23, 2019 Abandoned
Array ( [id] => 15206455 [patent_doc_number] => 20190365914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-05 [patent_title] => NOVEL ANTIBODY-DRUG CONJUGATES AND THE USE OF SAME IN THERAPY [patent_app_type] => utility [patent_app_number] => 16/381803 [patent_app_country] => US [patent_app_date] => 2019-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15032 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 520 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16381803 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/381803
Antibody-drug conjugates and the use of same in therapy Apr 10, 2019 Issued
Array ( [id] => 14833563 [patent_doc_number] => 20190275182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-12 [patent_title] => RADIOTRACER COMPOSITIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 16/375223 [patent_app_country] => US [patent_app_date] => 2019-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8054 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16375223 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/375223
Radiotracer compositions and methods Apr 3, 2019 Issued
Array ( [id] => 14833549 [patent_doc_number] => 20190275175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-12 [patent_title] => Carbon Nanotubes for Imaging and Drug Delivery [patent_app_type] => utility [patent_app_number] => 16/353743 [patent_app_country] => US [patent_app_date] => 2019-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9591 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16353743 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/353743
Carbon Nanotubes for Imaging and Drug Delivery Mar 13, 2019 Abandoned
Menu